Cargando…
P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428920/ http://dx.doi.org/10.1097/01.HS9.0000969140.27928.4f |
| _version_ | 1785090586205749248 |
|---|---|
| author | Cristiano, Gianluca Nanni, Jacopo Zannoni, Letizia Zingarelli, Federico Sartor, Chiara Sarah, Parisi Paolini, Stefania Papayannidis, Cristina Cavo, Michele Curti, Antonio |
| author_facet | Cristiano, Gianluca Nanni, Jacopo Zannoni, Letizia Zingarelli, Federico Sartor, Chiara Sarah, Parisi Paolini, Stefania Papayannidis, Cristina Cavo, Michele Curti, Antonio |
| author_sort | Cristiano, Gianluca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428920 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289202023-08-17 P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY Cristiano, Gianluca Nanni, Jacopo Zannoni, Letizia Zingarelli, Federico Sartor, Chiara Sarah, Parisi Paolini, Stefania Papayannidis, Cristina Cavo, Michele Curti, Antonio Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428920/ http://dx.doi.org/10.1097/01.HS9.0000969140.27928.4f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Cristiano, Gianluca Nanni, Jacopo Zannoni, Letizia Zingarelli, Federico Sartor, Chiara Sarah, Parisi Paolini, Stefania Papayannidis, Cristina Cavo, Michele Curti, Antonio P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY |
| title | P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY |
| title_full | P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY |
| title_fullStr | P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY |
| title_full_unstemmed | P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY |
| title_short | P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY |
| title_sort | p558: absolute lymphocyte count is an independent survival predictor compared to minimal residual disease in patients with acute myeloid leukemia treated with intensive chemotherapy |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428920/ http://dx.doi.org/10.1097/01.HS9.0000969140.27928.4f |
| work_keys_str_mv | AT cristianogianluca p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy AT nannijacopo p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy AT zannoniletizia p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy AT zingarellifederico p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy AT sartorchiara p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy AT sarahparisi p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy AT paolinistefania p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy AT papayannidiscristina p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy AT cavomichele p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy AT curtiantonio p558absolutelymphocytecountisanindependentsurvivalpredictorcomparedtominimalresidualdiseaseinpatientswithacutemyeloidleukemiatreatedwithintensivechemotherapy |